Whiteside T L, Miescher S, Hurlimann J, Moretta L, von Fliedner V
Int J Cancer. 1986 Jun 15;37(6):803-11. doi: 10.1002/ijc.2910370602.
Tumor-infiltrating lymphocytes (TIL) were obtained by a combination of mechanical release and enzymatic disaggregation from 35 human solid tumors. The number of lymphocytes in TIL-enriched suspensions varied from 1 X 10(4) to 7.6 X 10(6) per wet gram of tumor. The TIL preparations separated by differential centrifugation on Ficoll-Hypaque gradients contained 10-95% of T11+ cells (mean 50%), and tumor cells accounted for the other major cellular component. Macrophages, NK cells, B cells and granulocytes were infrequently seen. Morphologically, TIL-T were small non-activated cells. They expressed the T11 and T3 antigens but not the receptor for IL-2 (IL-2R) or HLA-DR antigens as determined by double immunofluorescence staining. Rare T11+/IL-2R+ cells were recovered only from colon and lung carcinomas. The mean T4/T8 ratio in 12 TIL preparations was 1.1 +/- 0.8. Immunohistology with monoclonal antibodies (MAbs) performed in 31/35 tumors confirmed that the T11+ cells infiltrating solid tumors rarely expressed the IL-2R and that the cell content of suspensions enriched in TIL was comparable to that determined in situ. The recovered TIL were cloned in a microculture system that permits proliferation of nearly all normal peripheral blood T lymphocytes (PBL-T). Under these culture conditions, frequencies of the proliferating T lymphocyte precursors (PTL-P) were depressed in both the TIL preparations (less than 0.01 to 0.39) and patients' PBL-T (0.05 to 0.5). These low frequencies of PTL-P were seen in patients with all tumor types, both primary and metastatic.
通过机械分离和酶解相结合的方法,从35例人类实体瘤中获取肿瘤浸润淋巴细胞(TIL)。富含TIL的悬液中淋巴细胞数量为每湿重克肿瘤1×10⁴至7.6×10⁶个。通过在Ficoll-Hypaque梯度上进行差速离心分离得到的TIL制剂中,T11⁺细胞占10% - 95%(平均50%),肿瘤细胞是另一个主要细胞成分。巨噬细胞、NK细胞、B细胞和粒细胞很少见。形态学上,TIL-T是小的未活化细胞。通过双免疫荧光染色确定,它们表达T11和T3抗原,但不表达IL-2受体(IL-2R)或HLA-DR抗原。仅从结肠癌和肺癌中回收了罕见的T11⁺/IL-2R⁺细胞。12份TIL制剂中的平均T4/T8比值为1.1±0.8。对31/35例肿瘤进行的单克隆抗体免疫组织化学检测证实,浸润实体瘤的T11⁺细胞很少表达IL-2R,且富含TIL的悬液中的细胞成分与原位测定的相当。回收的TIL在允许几乎所有正常外周血T淋巴细胞(PBL-T)增殖的微培养系统中进行克隆。在这些培养条件下,TIL制剂(小于0.01至0.39)和患者的PBL-T(0.05至0.5)中增殖性T淋巴细胞前体(PTL-P)的频率均降低。所有肿瘤类型(原发性和转移性)的患者均出现PTL-P的低频率。